Stem Cell Therapy for Pets: What It Can and Cannot Treat
Regenerative medicine has transformed how we think about treating injury and disease in human patients, and veterinary medicine has been following closely behind. Stem cell therapy for companion animals is no longer an experimental curiosity — it is a clinical reality offered by specialist veterinary centres and some general practices. But like any emerging treatment, it comes with genuine promise and genuine limitations that are worth understanding before you consider it for your pet.
How Does Stem Cell Therapy Work in Animals?
Stem cells are undifferentiated cells with the capacity to develop into multiple different tissue types. In veterinary practice, the most commonly used type is mesenchymal stem cells (MSCs), which can be derived from a pet's own fat tissue, bone marrow, or umbilical cord blood. Because these cells are harvested from the patient themselves — a process called autologous therapy — the risk of immune rejection is low.
Once harvested, the cells are processed in a laboratory to isolate and concentrate them, then injected directly into the affected area or administered intravenously. The mechanism of action involves more than simply replacing damaged tissue. MSCs release anti-inflammatory signals, modulate immune responses, and stimulate the animal's own repair processes. This makes them particularly valuable in conditions characterised by chronic inflammation.
Where the Evidence Is Strongest
Osteoarthritis in dogs is currently the most evidence-supported application for veterinary stem cell therapy. Multiple peer-reviewed studies have demonstrated improvements in mobility, pain scores, and quality of life following treatment, with effects that can persist for several months to over a year. Dogs with hip dysplasia, elbow dysplasia, and degenerative joint disease are the most common candidates.
Tendon and ligament injuries also show promising results, particularly in performance dogs and horses, where research into equine applications has been ongoing for longer. The ability of MSCs to promote collagen organisation and reduce scar tissue formation makes them a logical fit for these types of soft tissue damage.
In cats, feline chronic kidney disease has become an area of active investigation. Early clinical trials suggest that intravenously administered MSCs may slow disease progression and improve kidney function markers, though this research is still at a relatively early stage and should not yet be considered a standard treatment.
What Stem Cell Therapy Cannot Do
It is important to be clear about the boundaries of what this treatment can currently achieve. Stem cell therapy is not a cure. It does not reverse established joint degeneration, regrow cartilage that has already been destroyed, or repair severely damaged organs. In most cases, it is a tool for managing chronic conditions and slowing progression rather than eliminating disease.
The following conditions are frequently cited by providers but have weaker or more limited evidence behind them:
- Spinal cord injuries — some improvement has been reported, but results are inconsistent and the severity of the injury significantly influences outcome
- Inflammatory bowel disease — anecdotal reports exist but controlled trials in pets are limited
- Autoimmune conditions — theoretically relevant given MSC immune-modulating properties, but clinical data in companion animals is sparse
The veterinary stem cell sector is not without commercial pressure, and some providers make claims that outpace the available science. A critical eye and a conversation with a veterinary specialist — rather than a general practitioner with a financial interest in the treatment — is always worthwhile.
What to Expect From the Procedure
For an autologous procedure, your pet will typically undergo a minor surgical procedure under general anaesthesia to harvest fat tissue, usually from around the shoulder blade or abdomen. This sample is either processed on-site using a same-day system or sent to a specialist laboratory, which may take one to two weeks. The processed cells are then injected, often into the affected joint under sedation or light anaesthesia.
Side effects are generally mild and temporary, including localised swelling or temporary discomfort at the injection site. Serious adverse events are rare, particularly with autologous treatments. Allogeneic treatments — using cells from a donor animal — carry a slightly higher risk profile and are less commonly used in companion animals.
Cost and Accessibility
Stem cell therapy remains expensive. Depending on the provider, the condition being treated, and whether laboratory processing is involved, costs in the UK typically range from £1,500 to £4,000 per treatment cycle. Some animals require repeat treatments every six to twelve months to maintain the benefits, which adds to the long-term financial commitment.
Pet insurance policies vary significantly in whether they cover regenerative treatments, and it is worth checking your policy wording carefully before proceeding. Some insurers consider stem cell therapy experimental and will not reimburse it; others will cover it if it is prescribed by a registered veterinary specialist.
Questions to Ask Your Vet
- Is there published clinical evidence supporting this treatment for my pet's specific condition?
- What outcome can realistically be expected, and how will we measure it?
- Are there conventional treatments that should be tried first or used alongside this?
- Who will be performing the procedure and what is their training in regenerative medicine?
Stem cell therapy represents a genuinely exciting development in veterinary medicine, particularly for animals with chronic pain and degenerative conditions that respond poorly to conventional drugs. Approaching it with realistic expectations and good information puts you in the best position to decide whether it is the right choice for your animal.